Fluofarma's know how

What is Fluofarma's HCS?

Fluofarma’s High Content Screening (HCS) is a powerful drug discovery method that combines the highest level of information from cell biology experiments with industrial throughput and standards.
Our HCS technology is based on modern cell biology methods; it allows the simultaneous detection of multiple precise molecular and phenotypic cellular events. Fluofarma HCS technology is optimized for a wide range of substrates. Numerous cell lines are available along primary cell cultures and 3D microtissues in order to increase the relevance of the experiments, and thus provides you with the most predictive results possible.
The automation process allows a high throughput analysis of a whole population at the single cell level, exceeding the industrial requirements.

Fluofarma’s offer

Fluofarma’s divisions provide the most comprehensive High Content Screening offer on the market.
Fluofarma Bioengineering Division provides a unique opportunity for effortlessly and quickly implementing innovative HCS assays in your pipeline or uncovering the mechanisms of action of a drug.
Fluofarma Bioscreening gives you access to over 600 optimized assays to evaluate the effects of your compounds in the relevant cellular context within time and budget.